Dr Reddys Laboratories announces launch of generic Azacitidine for Injection

Image
Capital Market
Last Updated : Nov 02 2017 | 8:01 PM IST

In Canada

Dr Reddys Laboratories announced that generic Azacitidine for Injection 100mg/vial, bioequivalent generic version of VIDAZA, is approved by Health Canada. VIDAZA is trademark of Celgene.

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Nov 02 2017 | 7:47 PM IST

Next Story